Tracy Brightman

Tracy Brightman, PhD, is a seasoned professional in medical writing with extensive experience in the pharmaceutical industry. Currently serving as Senior Director of Medical Writing at EyePoint Pharmaceuticals since June 2022, Tracy has previously held prominent positions, including Director of Medical Writing at Moderna, where leadership in COVID-19 projects was a key focus. At AbbVie, Tracy excelled as Director of Global Medical Writing for Ophthalmology, contributing significantly to regulatory submissions, including LASTACAFT and OZURDEX. Tracy's expertise also extends to Allergan, Bristol-Myers Squibb, and Novartis, where roles involved managing complex regulatory documents and strategic oversight in clinical development. Academic credentials encompass a BS in Pharmacy from Northeastern University and a PhD in Pharmacology and Toxicology from the University of Medicine & Dentistry of New Jersey.